PNRI
The Seattle Times has published an op-ed by PNRI CEO, Jack Faris, PhD, and Interim Chief Scientific Officer & Senior Investigator, Aimée Dudley, PhD, highlighting the real-world consequences of when federal research funding is disrupted—not just for scientists, but for the millions of people waiting for a diagnosis, treatment, or cure.
Funding instability shuts down labs, stalls clinical trials, and pushes young scientists out of research. And it’s not just researchers who suffer. People of all political stripes—parents of children with rare diseases, families of Alzheimer’s patients, those newly diagnosed with cancer, and more—are caught in the crossfire.
We’re calling on policymakers to protect research funding from future disruptions. We’re also asking individuals to stand with us—whether by advocating for science or supporting independent research institutes like PNRI, which rely on visionary donors to keep discovery moving forward.
Click here to read the full op-ed in The Seattle Times.
“Federal funding for biomedical research is a partnership with the American people—an investment in a future where diseases are understood, treated, and ultimately prevented. When that funding is cut off, it doesn’t just slow scientific progress; it threatens the millions of lives that depend on discoveries made possible by this support.”
Jack Faris, PhD
PNRI Chief Executive Officer